• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events > Chagas Disease in the Americas: Improving Access and Tools for Patient Diagnosis and Treatment > Page 4

Chagas Disease in the Americas: Improving Access and Tools for Patient Diagnosis and Treatment

2 October 2009

Los Angeles, USA

  • Presentations
    • Overview
    • Symposium
    • Speaker Bios
    • Presentations
    • Symposium Articles
    • Materials
    • Background Papers
    • Campaign Documents
    • Press releases
    • Articles

Presentations

9:00 – 9:15 AM: Welcome

Claire Panosian, MD, Co-Director, UCLA Program in Global Health

Matthew Spitzer, MD, President, Médecins Sans Frontières

 

9:15 – 9:30 AM: Opening Address

Video message from Amelia Nascimento, Chagas patient support group, Sao Paulo, Brazil

Speech by Maira Gutierrez, Chagas patient, Los Angeles

 
Introductory Presentations: Setting the Stage

9:30 – 9:40 AM: National Programs for Chagas Disease in Latin America

James Fitzgerald, PhD, Senior Advisor, Essential Medicines and Biologicals, Pan American Health Organization (PAHO)/ World Health Organization (WHO)

9:40 – 9:50 AM: Epidemiological Trends of Chagas Disease in the US

Susan P. Montgomery, DVM, MPH, Parasitic Diseases Branch, Centers for Disease Control and Prevention (CDC)

 
Morning Session I: Challenges of Diagnosing and Treating Chagas Disease

10:00 – 11:30 AM: Panel Chair – James H. Maguire, MD, Professor of Medicine, Harvard Medical School; Senior Physician, Division of Infectious Disease, Brigham and Women’s Hospital

  • Global view of diagnostic testing for Chagas: Myriam Lorca, MSc, PhD, Associate Professor, Faculty of Medicine, University of Chile; Technical Director, Laboratoria Campus
  • Challenges of diagnostics in resource-poor contexts – MSF field experience: Laurence Flevaud, Laboratory Advisor, Médecins Sans Frontières/Doctors Without Borders
  • Blood screening and seroprevalence in the US: David A. Leiby, PhD, Head, Transmissible Diseases Department, American Red Cross
  • Chagas treatment in Bolivia, the world’s highest endemic country: Tom Ellman, MD, Head of Mission, Bolivia, Médecins Sans Frontières/Doctors Without Borders
  • Chagas treatment in the US: Sheba Meymandi, MD/Mahmoud Traina, MD, Olive View-UCLA Medical Center
Panel Discussion – First Respondent: Joaquim Gascón, MD, Head of Tropical Section, Hospital Clinic de Barcelona-CRESIB
 
Morning Session II: Patient Advocacy and Access to Care – Breaking Through the Barriers

11:45 AM – 1:00 PM: Roundtable on the multilevel barriers hindering patient access to care in Latin America and the US and proposed solutions: 5-min introductions and presentation of issues followed by group discussion – Moderator: Gemma Ortiz M Genovese, BSc(Hon), MSc, Neglected Diseases Senior Advocacy & Liaison Officer, Médecins Sans Frontières/Doctors Without Borders

  • Sergio Sosa-Estani, MD, MPH PhD, Head, Service of Epidemiology, National Center for Research on Endemic Diseases/ANLIS, Argentina
  • Victor Condé, MD, Physician, Bolivia Chagas treatment program, Médecins Sans Frontières/Doctors Without Borders
  • Eliana T. Loveluck, MSW, Director, Center for Consumers, The National Alliance for Hispanic Health
  • Janine Ramsey Willoquet, PhD, Director, Regional Center for Public Health Research, National Institute for Public Health, Mexico
  • Maira Gutierrez, Los Angeles-area patient
Afternoon Session I: Chagas Disease R&D and Innovation

2:00 – 3:30 PM: Panel Chair: Julio Urbina, PhD, Emeritus Investigator, Venezuelan Institute for Scientific Research (IVIC)

  • Global drug development pipeline for Chagas disease: Isabela Ribeiro, MD, Senior Project Manager, Drugs for Neglected Diseases initiative (DNDi)
  • Drug production and technology transfer in Brazil: Davi Santana, Technical Director, LAFEPE
  • Improving diagnostic tools: Rick Tarleton, PhD, President, The Chagas Disease Foundation, and Distinguished Research Professor, Center for Tropical and Emerging Global Diseases, University of Georgia
  • Search for better Chagas drugs: discovery research efforts: Frederick S. Buckner, MD, Associate Professor, Department of Medicine, University of Washington
Afternoon Session II: Sustainable Funding and Innovative Financing Mechanisms

3:45 – 4:45 PM: Panel Chair: Jana Armstrong, Executive Director, Drugs for Neglected Diseases initiative (DNDi) North America

  • Overview of alternative financing mechanisms: prize funds, advance purchase commitments, patent pools, and voucher systems: Paul Wilson, Assistant Professor of Public Health, Columbia University
  • Chagas disease prize fund for the development of new transfers, diagnostics, and vaccines: Erika Dueñas, Charge d’Affaires, Deputy Chief of Mission, Embassy of Bolivia
  • Pharmaceutical industry perspective on investing in NTD R&D: Drew Lewis, MD, Head, Infectious Diseases Emerging Markets, Pfizer, Inc.
  • Incentivizing Innovative Therapeutics for Chagas Disease: David N. Cook, PhD, BIO Ventures for Global Health
  • Private sector incentives for NTD R&D: Hannah Kettler, PhD, Senior Program Officer and Economist, Global Health Policy and Finance, Bill and Melinda Gates Foundation

4:45 – 5:15 PM: Wrap-Up – Presentation and discussion of consensus statements and calls for action

Eric Stobbaerts, Policy & Advocacy Coordinator for Chagas Campaign, Drugs for Neglected Diseases initiative (DNDi); Oliver Yun, Medical Editor, Médecins Sans Frontières/Doctors Without Borders

5:15 – 5:30 PM: Closing Remarks

Bernard Pecoul, MD, Executive Director, Drugs for Neglected Diseases initiative (DNDi)

Pages: Page 1, Page 2, Page 3, Page 4, Page 5, Page 6, Page 7, Page 8, Page 9, Page 10
Chagas disease

Other events

Loading...
15-20 June 2025

Kigali, Rwanda

Twelfth EDCTP Forum

15-18 June 2025

Manila, Philippines

8th Asia Dengue Summit

22 May 2025

Online event

MSF Scientific Days

21 May 2025, 9-10:30 AM

Geneva, Switzerland

Scaling impact: Climate & health solutions that drive change

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License